201 related articles for article (PubMed ID: 34342761)
1. The upregulation of oncogenic miRNAs in swabbed samples obtained from oral premalignant and malignant lesions.
Lin SC; Liu CJ; Ji SH; Hung WW; Liu YC; Chang SR; Tu HF; Chang KW
Clin Oral Investig; 2022 Feb; 26(2):1343-1351. PubMed ID: 34342761
[TBL] [Abstract][Full Text] [Related]
2. Aberrant
Tu HF; Chang KW; Lin SC; Hung WW; Ji SH; Wu HL; Liu CJ
J Dent Sci; 2022 Apr; 17(2):688-695. PubMed ID: 35756791
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Diagnostic Significance of Salivary miRNA-184 and miRNA-21 in Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Garg A; Urs AB; Koner BC; Augustine J; Guru SA
Head Neck Pathol; 2023 Dec; 17(4):961-968. PubMed ID: 38015343
[TBL] [Abstract][Full Text] [Related]
4. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
[TBL] [Abstract][Full Text] [Related]
5. Salivary miRNAs Expression in Potentially Malignant Disorders of the Oral Mucosa and Oral Squamous Cell Carcinoma: A Pilot Study on miR-21, miR-27b, and miR-181b.
Di Stasio D; Romano A; Boschetti CE; Montella M; Mosca L; Lucchese A
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612284
[TBL] [Abstract][Full Text] [Related]
6. MiRNAs as non-invasive biomarkers in the serum of Oral Squamous Cell Carcinoma (OSCC) and Oral Potentially Malignant Disorder (OPMD) patients.
Mazumder S; Basu B; Ray JG; Chatterjee R
Arch Oral Biol; 2023 Mar; 147():105627. PubMed ID: 36657275
[TBL] [Abstract][Full Text] [Related]
7. A Noninvasive Test for MicroRNA Expression in Oral Squamous Cell Carcinoma.
Gissi DB; Morandi L; Gabusi A; Tarsitano A; Marchetti C; Cura F; Palmieri A; Montebugnoli L; Asioli S; Foschini MP; Scapoli L
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29914173
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-based classifiers for diagnosis of oral cavity squamous cell carcinoma in tissue and plasma.
Pedersen NJ; Jensen DH; Lelkaitis G; Kiss K; Charabi BW; Ullum H; Specht L; Schmidt AY; Nielsen FC; von Buchwald C
Oral Oncol; 2018 Aug; 83():46-52. PubMed ID: 30098778
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-31 upregulation predicts increased risk of progression of oral potentially malignant disorder.
Hung KF; Liu CJ; Chiu PC; Lin JS; Chang KW; Shih WY; Kao SY; Tu HF
Oral Oncol; 2016 Feb; 53():42-7. PubMed ID: 26675284
[TBL] [Abstract][Full Text] [Related]
10. miR-146a promotes proliferation, invasion, and epithelial-to-mesenchymal transition in oral squamous carcinoma cells.
Wang F; Ye LJ; Wang FJ; Liu HF; Wang XL
Environ Toxicol; 2020 Oct; 35(10):1050-1057. PubMed ID: 32469461
[TBL] [Abstract][Full Text] [Related]
11. Plasma miR-187* is a potential biomarker for oral carcinoma.
Liu CJ; Lin JS; Cheng HW; Hsu YH; Cheng CY; Lin SC
Clin Oral Investig; 2017 May; 21(4):1131-1138. PubMed ID: 27324473
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
[TBL] [Abstract][Full Text] [Related]
13. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
[TBL] [Abstract][Full Text] [Related]
14. Salivary exosomal miR-24-3p serves as a potential detective biomarker for oral squamous cell carcinoma screening.
He L; Ping F; Fan Z; Zhang C; Deng M; Cheng B; Xia J
Biomed Pharmacother; 2020 Jan; 121():109553. PubMed ID: 31704611
[TBL] [Abstract][Full Text] [Related]
15. A Novel Saliva and Serum miRNA Panel as a Potential Useful Index for Oral Cancer and the Association of miR-21 with Smoking History: a Pilot Study.
Vageli DP; Doukas PG; Shah R; Boyi T; Liu C; Judson BL
Cancer Prev Res (Phila); 2023 Dec; 16(12):653-659. PubMed ID: 37683274
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma.
Romani C; Salviato E; Paderno A; Zanotti L; Ravaggi A; Deganello A; Berretti G; Gualtieri T; Marchini S; D'Incalci M; Mattavelli D; Piazza C; Bossi P; Romualdi C; Nicolai P; Bignotti E
Theranostics; 2021; 11(6):2987-2999. PubMed ID: 33456584
[TBL] [Abstract][Full Text] [Related]
17. miR-146a enhances the oncogenicity of oral carcinoma by concomitant targeting of the IRAK1, TRAF6 and NUMB genes.
Hung PS; Liu CJ; Chou CS; Kao SY; Yang CC; Chang KW; Chiu TH; Lin SC
PLoS One; 2013; 8(11):e79926. PubMed ID: 24302991
[TBL] [Abstract][Full Text] [Related]
18. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
[TBL] [Abstract][Full Text] [Related]
19. Exosome-derived microRNAs in oral squamous cell carcinomas impact disease prognosis.
Chen CM; Chu TH; Chou CC; Chien CY; Wang JS; Huang CC
Oral Oncol; 2021 Sep; 120():105402. PubMed ID: 34174519
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375 Inhibits Growth and Enhances Radiosensitivity in Oral Squamous Cell Carcinoma by Targeting Insulin Like Growth Factor 1 Receptor.
Zhang B; Li Y; Hou D; Shi Q; Yang S; Li Q
Cell Physiol Biochem; 2017; 42(5):2105-2117. PubMed ID: 28810236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]